Latest AI and machine learning research in breast cancer for healthcare professionals.
Spatial transcriptomics (ST) assays are transforming our understanding of tumor heterogeneity, but their high cost limits their application in large-scale biomarker discovery. Here, we present "Path2Space," a deep-learning model that predicts spatial gene expression directly from histopathology slides. Trained on extensive breast cancer ST data, Path2Space robustly predicts the spatial expression ...
Muscle-invasive bladder cancer (MIBC) presents with variable clinical and pathological features, leading to inconsistent responses to standard treatments such as neoadjuvant chemotherapy (NAC). Although transcriptome profiling has shown differences in NAC response, reliable predictors of treatment outcome remain elusive. Here this study aimed to improve NAC response prediction by integrating multi...
Growth differentiation factor-15 (GDF15), a stress-responsive cytokine of the transforming growth factor-β superfamily, is elevated in cancer cachexia...
BACKGROUND: Intrahepatic cholangiocarcinoma (iCCA) is a highly aggressive liver malignancy characterized by an adverse outcome attributed to delayed d...
TB remains a significant global health burden due to protracted therapeutic courses, poor patient compliance, and toxicities associated with drug trea...
PURPOSE OF REVIEW: Multidrug-resistant Gram-negative bloodstream infections (MDR-GNBSI) are increasingly frequent in immunocompromised hosts, particul...
OBJECTIVE: To evaluate the effects of arm positioning and reconstruction algorithms on radiation dose and image quality of abdominal CT. MATERIALS AND...
Pancreatic ductal adenocarcinoma remains one of the deadliest malignancies, characterized by late diagnosis, aggressive biology and limited therapeuti...
Prognostic stratification in gastric cancer (GC) currently relies on the tumour-node-metastasis (TNM) staging system, which incompletely captures tumo...
The interplay between mitochondria and programmed cell deaths (PCD) is associated with tumor pathogenesis. However, the specific roles of genes relate...
Triaptosis, an emerging form of cell death, remains poorly characterized in terms of its heterogeneity within clear cell renal cell carcinoma (ccRCC)....
This literature review examines the transformative role of machine learning (ML) and deep learning (DL) in enhancing optical spectroscopy for breast c...
Background:The enhancement of the therapeutic window (TW) in oncology remains a significant challenge, as the majority of anticancer treatments face d...
This invited commentary grew out of a presentation made at the 2025 ConRad Meeting in Munich, Germany, and summarizes talks made by researchers suppor...
Positron emission tomography (PET) has been used in pediatric oncology since the modality gained traction 20 years ago but has been used more sparingl...
Ductal Carcinoma In Situ (DCIS) is a non-obligate precursor of invasive breast cancer. Due to a lack of reliable prognostic markers, nearly all women ...
OBJECTIVE: To address the critical issue of compromised image quality and diagnostic accuracy in low-dose computed tomography (LDCT) due to increased ...
Treatment outcome prediction plays an important role in realizing personalized cancer therapy. In triple-negative breast cancer (TNBC), neoadjuvant ch...
INTRODUCTION: Renal cell carcinoma (RCC) most commonly metastasizes to the lungs and shares risk factors with lung cancer. However, primary lung cance...
CONTEXT.—: Advances in computer vision have fueled the development of artificial intelligence (AI)-based algorithms for pathology. AI-assisted approac...